Topic:Vaccination

Vaccination in horses involves the administration of antigenic material to stimulate an immune response, providing protection against specific infectious diseases. This process is a key component of preventive equine healthcare, aiming to reduce the incidence and severity of illnesses such as equine influenza, tetanus, and West Nile virus. Vaccines can be administered via various routes and may contain live attenuated, inactivated, or subunit components. The immune response elicited by vaccination helps in the development of immunological memory, enabling horses to respond more effectively upon exposure to the actual pathogen. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in equine populations.

Hyperimmunization of horses with alpha toxoid of Clostridium perfringens.

Japanese journal of medical science & biology April 1, 1970 Volume 23, Issue 2 111-115 doi: 10.7883/yoken1952.23.111

Yanamoto A, Ito A, Murata R, Uematsu N, Nagai K.No abstract available

Canadian journal of comparative medicine : Revue canadienne de medecine comparee January 1, 1970 Volume 34, Issue 1 1-5

Rouse BT, Ditchfield WJ.The antibody response in serum and nasal secretions of groups of ponies vaccinated or infected with Myxovirus influenzae A-equi 2 was examined. Following infection by aerosol with live virus, a weak antibody response was recorded in both serum and secretions. Antibody levels were undetectable in secretions at 31 days after infection. After primary intramuscular vaccination with killed virus, using sodium alginate as an adjuvant, antibody was detected only in the serum. However, following revaccination, a pronounced antibody response was demonstrated in both serum and secretions. Antibody was s...

Read More 3

[Rabies vaccination of the horse].

Berliner und Munchener tierarztliche Wochenschrift September 15, 1969 Volume 82, Issue 18 341-342

Jaeger O, Barth R.No abstract available

Wiener tierarztliche Monatsschrift September 1, 1969 Volume 56, Issue 7 275-280

Kubin G, Kölbl O.No abstract available

Journal of the American Veterinary Medical Association July 15, 1969 Volume 155, Issue 2 312-314

Bittle JL.No abstract available

Journal of the American Veterinary Medical Association July 15, 1969 Volume 155, Issue 2 376-379

Tamoglia TW.No abstract available

Read More 0

Mixed equine bacterins.

Journal of the American Veterinary Medical Association July 15, 1969 Volume 155, Issue 2 432

Phillips CE.No abstract available

Journal of the American Veterinary Medical Association July 15, 1969 Volume 155, Issue 2 272-277

Todd JD.No abstract available

The Cornell veterinarian January 1, 1969 Volume 59, Issue 1 29-34

Wilson JC.No abstract available

Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B April 1, 1968 Volume 15, Issue 3 406-418

Mayr A, Pette J, Petzoldt K, Wagener K.No abstract available

Applied microbiology July 1, 1967 Volume 15, Issue 4 968-969 doi: 10.1128/am.15.4.968-969.1967

Berman S, Lowenthal JP, Sorrentino JV, White AB.No abstract available

Bulletin - Office international des epizooties July 1, 1967 Volume 67, Issue 7 949-959

Ozawa Y, Hazrati A.No abstract available

Canadian journal of comparative medicine and veterinary science November 1, 1966 Volume 30, Issue 11 311-314

Ozawa Y, Bahrami S.Formalized African horse-sickness (AHS) type 9 virus cultivated in monkey kidney stable (MS) cell cultures was experimentally used for immunizing horses. Inactivated vaccines prepared either from viscerotropic or neurotropic type 9 AHS virus produced antibodies in vaccinated horses. Immunity developed in all horses vaccinated with various amounts of the vaccine, and protected them from infection, when challenged 5 weeks after vaccination.